Abstract
Clostridium difficile infection (CDI) is one of the most common gastrointestinal complication after antimicrobial treatment. It is estimated that CDI after pneumonia treatment is connected with a higher mortality than other causes of hospitalization. The aim of the study was to assess the relationship between the kind of antibiotic used for pneumonia treatment and mortality from post-pneumonia CDI. We addressed the issue by examining retrospectively the records of 217 patients who met the diagnostic criteria of CDI. Ninety four of those patients (43.3 %) came down with CDI infection after pneumonia treatment. Fifty of the 94 patients went through severe or severe and complicated CDI. The distribution of antecedent antibiotic treatment of pneumonia in these 50 patients was as follows: ceftriaxone in 14 (28 %) cases, amoxicillin with clavulanate in 9 (18 %), ciprofloxacin in 8 (16.0 %), clarithromycin in 7 (14 %), and cefuroxime and imipenem in 6 (12 %) each. The findings revealed a borderline enhancement in the proportion of deaths due to CDI in the ceftriaxone group compared with the ciprofloxacin, cefuroxime, and imipenem groups. The corollary is that ceftriaxone should be shunned in pneumonia treatment. The study demonstrates an association between the use of a specific antibiotic for pneumonia treatment and post-pneumonia mortality in patients who developed CDI.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bagdasarian N, Rao K, Malani PN (2015) Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA 313(4):398–408
Becerra MB, Becerra BJ, Banta JE, Safdar N (2015) Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalization: an analysis of the nationwide inpatient sample. BMC Infect Dis 15:254. doi:10.1186/s12879-015-0925-9
Britton RA, Young VB (2014) Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 146(6):1547–1553
Brown K, Valenta K, Fisman D, Simor A, Daneman N (2015) Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Int Med 175(4):626–633
Büchler AC, Rampini SK, Stelling S, Ledergerber B, Peter S, Schweige A, Speck RF (2014) Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich. BMC Infect Dis 14(1):607. doi:10.1186/s12879-014-0607-z
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31(05):431–455
Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ (2008) Short-and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 46(4):497–504
Dubberke ER, Haslam DB, Lanzas C, Bobo LD, Burnham CA, Gröhn YT, Tarr PI (2011) The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge. Zoonoses Public Health 58(1):4–20
DuPont HL (2013) Diagnosis and management of Clostridium difficile infection. Clin Gastroenterol Hepatol 11(10):1216–1223
Gabriel L, Beriot-Mathiot A (2014) Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review. J Hosp Infect 88(1):12–21
Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW (2010) Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 74(4):309–318
Hernández-García R, Garza-González E, Miller M, Arteaga-Muller G, Galván-de los Santos AM, Camacho-Ortiz A (2015) Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico. Braz J Infect Dis 19(4):399–402
Hoover DG, Rodriguez-Palacios A (2013) Transmission of Clostridium difficile in foods. Infect Dis Clin North Am 27(3):675–685
Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Szathmari M (2015) Burden of Clostridium difficile infection between 2010 and 2013: trends and outcomes from an academic center in Eastern Europe. World J Gastroenterol 21(21):6728–6735
Lund BM, Peck MW (2015) A possible route for foodborne transmission of Clostridium difficile? Foodborne Pathog Dis 12(3):77–182
Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Ray SM (2014) Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370(13):1198–1208
Paredes-Sabja D, Shen A, Sorg JA (2014) Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol 22(7):406–416
Phillips ST, Nagaro K, Sambol SP, Johnson S, Gerding DN (2011) Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones. Anaerobe 17(4):166–169
Schiller LR, Pardi DS, Spiller R, Semrad CE, Surawicz CM, Giannella RA, Sellin JH (2014) Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis. J Gastroenterol Hepatol 29(1):6–25
Slimings C, Riley TV (2014) Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 69(4):881–891
Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, Zuckerbraun BS (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108(4):478–498
Winslow BT, Onysko MARY, Thompson KA, Caldwell K, Ehlers GH (2014) Common questions about Clostridium difficile infection. Am Fam Physician 89(6):437–442
Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, Bates DW (2013) Health care–associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Int Med 173(22):2039–2046
Conflicts of Interests
The authors had no conflicts of interest to declare in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Zycinska, K. et al. (2016). Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection. In: Pokorski, M. (eds) Advancements in Clinical Research. Advances in Experimental Medicine and Biology(), vol 952. Springer, Cham. https://doi.org/10.1007/5584_2016_72
Download citation
DOI: https://doi.org/10.1007/5584_2016_72
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48032-9
Online ISBN: 978-3-319-48033-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)